Nov 18, 2020 / 04:30PM GMT
Sara Parigian -
Good afternoon, and welcome to Part 1 of the 2-part KOL Webinar series hosted by Arrowhead Pharmaceuticals. (Operator Instructions) As a reminder, this conference is being recorded, and a replay will be made available on the Arrowhead website following the event. I would now like to turn the call over to your host, Vince Anzalone, Vice President of Investor Relations at Arrowhead Pharmaceuticals. Please go ahead, sir.
Vincent Anzalone - Arrowhead Pharmaceuticals, Inc. - VP of IR
Thank you, Sara. Next slide, please. So I'm just going to give a quick welcome and introduction. We've got a lot to cover, so we will be quick to get to the content.
Next slide, please. So just reminding everybody that we will be making forward-looking statements today. So please refer to our regulatory filings for the risks to be considered in that regard.
Next slide. So we've got a very good panel today. We're fortunate to have Dr. Christie Ballantyne, who is from the Baylor College of Medicine. He's the Chief of Cardiology and the Chief of Cardiovascular
Arrowhead Pharmaceuticals Inc Key Opinion Leader Webinar on ARO-APOC3 Transcript
Nov 18, 2020
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers